Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…lite unstable CRC responds exceptionally well to treatment with immune checkpoint inhibitors, thereby proving that CRC is in principle amenable to immunothe…
…Across age groups, women had higher odds of admission being for malaria, AWD, LRTIs, chronic non-infectious respiratory diseases and ac…
…articipants with resectable HCC received 2 doses of neoadjuvant cemiplimab 350 mg IV every 3 weeks before surgical resection and 8 cycles …
…he only grade 3 AE observed, in 1 subject receiving 70 μg/kg of JL18008. The dose range of 20 to 70 μg/kg is anticipated to be the effe…
…rated encouraging efficacy when used as neoadjuvant therapy for Merkel cell carcinoma. Transcriptomic profiling on matched pairs of pre- and post-the…
…used, which can achieve more clinical benefits to patients with liver cirrhosis and overt HE.Ethics and dissemination The study has been approv…
…Background Cervical cancer, driven by persistent high-risk HPV infection, accounts for mor…
…32%). In FL, CAR-T products such as axicabtagene ciloleucel and lisocabtagene maraleucel achieve CR rates up to 94%, with median durations of remission …
…ch success in hematological cancers, ACT efficacy is limited in solid tumors due to poor tumor infiltration and immunosuppressive tumor micr…
… modulating the host immune system and influencing responses to anticancer therapies. Recent studies have highlighted the presence of complex microb…
…ds, and anti-CD38 monoclonal antibodies such as daratumumab and isatuximab. CD38 is expressed at high levels in the hematopoietic system, …
…h evidence of biological and therapeutic activities.Conclusions JEN-101 was safe and biologically active in dogs with advanced melanoma…